Evaluation of Anorexia in Cancer and Its Association with Autonomic Nervous System Activity Assessed by Heart Rate Variability
-
Published:2023-11-28
Issue:23
Volume:15
Page:4936
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
Molfino Alessio1ORCID, Gallicchio Carmen1, Imbimbo Giovanni1, Melena Michele1, Antonini Silvia1, Gigante Antonietta1ORCID, Muscaritoli Maurizio1
Affiliation:
1. Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy
Abstract
Alterations in the central nervous system in cancer patients are pivotal in determining appetite dysregulation and body weight loss (BWL). Autonomic nervous system activity was tested by measuring heart rate variability (HRV) in cancer patients presenting with anorexia. We considered inpatients with different types of cancer and investigated anorexia using their FAACT scores. HRV was evaluated by a three-channel Holter ECG. The domains of low frequencies (LF, sympathetic activity) and high frequencies (HF, parasympathetic activity) were calculated. Also, SDNN (autonomic activity) and RMSSD (parasympathetic activity) were assessed. We enrolled 56 patients with cancer and 23 controls. In cancer patients, RMSSD and SDNN were lower than in controls (p < 0.001 and p = 0.009). Sympathetic activity (LF nu) was lower in cancer patients than in controls (p = 0.023), including sympathovagal balance (LF/HF nu ratio) (p = 0.025). RMSSD was reduced in anorexic (p < 0.001) and non-anorexic (p = 0.003) cancer patients compared to controls. The SDNN was lower in anorexic cancer patients than in non-anorexic cancer patients (p = 0.025), and it was lower in anorexic cancer patients than in controls (p = 0.001). LF nu was lower in anorexic cancer patients than in controls (p = 0.015), as was LF/HF (p = 0.031). SDNN was negatively correlated with BWL in the cancer group (rho = −0.40; p = 0.007). Our data support the hypothesis that autonomic nervous system dysregulation exists in patients with cancer presenting with anorexia, with implications for its diagnosis and treatment.
Funder
Department of Translational and Precision Medicine, Sapienza University of Rome
Subject
Food Science,Nutrition and Dietetics
Reference39 articles.
1. Muscaritoli, M., Modena, A., Valerio, M., Marchetti, P., Magarotto, R., Quadrini, S., Narducci, F., Tonini, G., Grassani, T., and Cavanna, L. (2023). The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. Cancers, 15. 2. Cancer-associated anorexia: Validity and performance overtime of different appetite tools among patients at their first cancer diagnosis;Molfino;Clin. Nutr.,2021 3. Bossi, P., Delrio, P., Mascheroni, A., and Zanetti, M. (2021). The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients, 13. 4. Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia;Yeom;Exp. Mol. Med.,2022 5. Abraham, M., Kordatou, Z., Barriuso, J., Lamarca, A., Weaver, J.M.J., Cipriano, C., Papaxoinis, G., Backen, A., and Mansoor, W. (2019). Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer. PLoS ONE, 14.
|
|